CLAY B SIEGALL Insider Trading $SYBX SYNLOGIC, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CLAY B SIEGALL.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CLAY B SIEGALL. CLAY B SIEGALL is President & CEO in SEATTLE GENETICS INC /WA ($SGEN) and President and CEO in SEATTLE GENETICS INC /WA ($SGEN) and See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Mirna Therapeutics, Inc. ($MIRN).

CLAY B SIEGALL in SYNLOGIC, INC.

Trading Symbol: SYBX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CLAY B SIEGALL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 06 2016
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of CLAY B SIEGALL in SYNLOGIC, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALDR, SGEN, SYBX, RARE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 06 2016MIRNMirna Therapeutics ...SIEGALL CLAY BDirectorOption ExerciseA4.7410,00047,40010,000
Sep 30 2015MIRNMirna Therapeutics ...SIEGALL CLAY BDirectorOption ExerciseA7.0012,00084,00012,000

Page:   1